Clinical trial Recruiting at 1 site Interventional Ages 78 and up

Catheter ablation vs optimized medical care for very elderly with atrial fibrillation

Official title: Assessment of the Effect of Catheter Ablation on Elderly Population With Atrial Fibrillation; a Randomized Controlled Study; The ACE-AF Study

Run by Karolinska University Hospital · NCT07424690 · Data updated 2026-11-12

In people aged 78 and up with AF, this study tests whether catheter ablation can help by comparing it to tailored medical therapy, using a wearable rhythm monitor to track AF over time.

More Atrial Fibrillation (AF) trials

Quick facts

Study typeInterventional
Ages78 Years and up
SexAll
Enrollment282 (estimated)
SponsorKarolinska University Hospital
Academic / other
Locations2 sites (Linköping and 1 other locations)
StatusRecruiting
StartedOctober 5, 2026
Main results expectedDecember 15, 2031
Study endsSeptember 15, 2034
Registry record updatedOctober 8, 2026
Trial IDNCT07424690 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 78 years or older with symptomatic AF, suitable for ablation, and with acceptable comorbidity (Charlson index ≤7).

Probably not a fit

Patients with high operative risk, significant left atrial enlargement, recent major cardiac events, or contraindications to anticoagulation may be less likely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

ACE-AF is a multicenter randomized trial evaluating catheter ablation against optimized medical therapy in adults 78 years and older with symptomatic AF. Participants are assigned 1:1 to ablation with standard rhythm-control strategies or to optimized medical therapy without ablation, with an implantable loop recorder continuously measuring AF burden. The trial uses contemporary ablation practices, prioritizing pulmonary vein isolation, and allows AV node ablation with pacemaker if clinically indicated. Randomization is stratified by sex and age group, and outcomes focus on rhythm and clinical endpoints while monitoring safety in an older population.

Why it matters

Potential benefit: If successful, the ablation strategy could offer better rhythm control and quality of life for very elderly patients with AF.

How similar studies have gone: Prior trials of AF ablation in older adults are limited; this pragmatic, randomized design with continuous rhythm monitoring is innovative in this age group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥78 years.
2. ECG-documented atrial fibrillation.
3. AF type: paroxysmal, persistent, or longstanding persistent AF.
4. Suitable candidate for catheter ablation according to ESC guidelines.
5. Charlson's comorbidity index ≤7.

Exclusion Criteria:

1. Left atrial (LA) dimension \>55 mm, based on echocardiography within the previous year.
2. Acute coronary syndrome or coronary artery bypass surgery within the last 12 weeks.
3. Severe valvular heart disease (per ESC definitions) or congenital heart disease.
4. Prior surgical or catheter AF ablation procedure, or prior AV-node (atrioventricular nodal) ablation.
5. Contraindication to oral anticoagulation.
6. AF due to a reversible cause.
7. Medical condition likely to limit survival to \<12 months.
8. Unable or unwilling to provide informed consent.
9. History of non-compliance with medical therapy.
10. BMI \<18 or \>37 kg/m².

Where it's running

  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting
  • Linköping University Hospital
    Linköping, Sweden
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.